In addition, we observed co-expression of immune mediators, such as interferons and their targets (IFNA1-2, IFNA7-8, IFNB1, and IFNG), as well as proinflammatory cytokines (IL-1B and IL12B) and chemokines and their receptors (CXCL9-11 and CXCR3) by CpG(B)-STAT3dODN-treated lymphoma cells (Figure 3A, right). This evidence concerns the gene IFNB1 and lymphoma.